**Summary**
Bellevue Healthcare Trust PLC has announced a series of proposed changes and a general meeting scheduled for March 4, 2026. The key proposals include
1. **Adoption of a New Investment Policy**: Implementing a long/short investment strategy to mitigate risk and capture alpha-generating opportunities in the healthcare and biotech sectors.
2. **Change of Investment Manager**Appointing Columbia Threadneedle as the new investment manager, replacing Bellevue Asset Management (UK) Limited.
3. **Tender Offer**Offering shareholders the option to tender up to 100% of their shares at a 2% discount to the net asset value (NAV) as of March 3, 2026.
4. **Matching Facility**Allowing incoming investors to acquire tendered shares at the same price.
5. **Name Change**Renaming the company to CT Healthcare Trust plc.
6. **Ameriprise Financial Investment**Ameriprise Financial intends to subscribe for up to $25 million of new shares to support scale and liquidity.
7. **Replacement of Redemption Facility**: Introducing quarterly tender offers instead of the existing redemption facility and zero discount policy.
The proposals are conditional on shareholder approval and the satisfaction of certain conditions, including a minimum net asset value of £55 million post-tender. If approved, Columbia Threadneedle’s appointment will become effective on March 5, 2026. The board unanimously recommends shareholders vote in favor of the resolutions, highlighting the potential benefits of the differentiated long/short strategy and Columbia Threadneedle’s strong track record in healthcare investments. Shareholders who do not wish to participate in the tender offer can remain invested, with the company maintaining its target annual dividend of 3.5% of the preceding year-end NAV.